Find and Pitch Jounalists, Get Your Story Covered

Tags: cancer, cancer immunology, cancer immunotherapy, cancer research, cell therapy, immunology breast cancer metastasis PCSK9 gene Stage 0

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Can Tumor Mutational Burden Guide Treatment in Metastatic Breast Cancer? - about 1 month ago Testing Elacestrant With Other Targeted Drugs for Metastatic Breast Cancer - about 1 month ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 7 months ago Breast Cancer Highlights From ASCO 2024 - 8 months ago Exercise Improved Quality of Life for Metastatic Breast Cancer Patients - about 1 year ago MeCo Score May Predict Metastatic Progression in Breast Cancer - about 1 year ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - about 1 year ago Financial Toxicity Among Single Mothers With Metastatic Breast Cancer - about 1 year ago Adding Tucatinib to T-DM1 Shows PFS Benefit in HER2-Positive Breast Cancer - about 1 year ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: The Persistent Association Between Obesity and Breast Cancer Outcomes - about 2 months ago SABCS 2024: Anthracyclines May Improve Survival in High-Risk Breast Cancer, But Risks Must Be Weighed - about 2 months ago SABCS 2024: Harnessing the Power of Tumor-Infiltrating Lymphocytes to Revolutionize Breast Cancer Treatment - about 2 months ago SABCS 2024: Risk-Reducing Surgeries Linked to Improved Survival in Young BRCA Carriers with Breast Cancer - about 2 months ago FDA Grants Breakthrough Therapy Designation to DS-8201a and T-DXd to Treat Metastatic Breast Cancer - 6 months ago FDA Approves Pembrolizumab Plus Chemotherapy to Treat Metastatic HER2-Negative Gastric, Gastroesophageal Junction Adenocarcinoma - about 1 year ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Better Quality of Life With RT vs Endocrine Therapy in Older Breast Cancer Patients - about 2 months ago Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer - about 2 months ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - 6 months ago Futile Immunotherapy for Cancer Grows More Common - about 1 year ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - over 1 year ago Pembrolizumab in First-Line Boosts PFS in HER2-Positive Stomach Cancer - over 1 year ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - 4 months ago Advancements in HER2+ Breast Cancer Treatment: Insights From the HER2CLIMB-02 Trial - 12 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Local Therapy Developments Hold Promise for Survival Improvements for NSCLC - 5 months ago Samsung Bioepis Initiates Phase 1 Trial for Proposed Keytruda Biosimilar - 11 months ago Neoadjuvant Chemotherapy Could Help Patients With Breast Cancer Skip Regional Nodal Irradiation - about 1 year ago
6	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - 7 months ago
7	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Balancing Clinical and Economic Factors in Early Breast Cancer Treatment - 8 months ago Unmet Needs in mBC Treatment Landscape - about 1 year ago Navigating Medication Therapy Management in mBC Treatment - about 1 year ago Hormone Therapy in Patients with HR+/HER2- Metastatic Breast Cancer - over 1 year ago
8	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	New Research Avenues Provide Hope for Metastatic Disease - 10 months ago Defining the Triple Negative Breast Cancer Morpholome - 12 months ago
9	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - about 1 year ago Abemaciclib, NSAI Extend Overall Survival for Patients With Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer - about 1 year ago Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer - about 1 year ago Study: Patients With PD-L1-Positive, High-Risk, ER+/HER2- Breast Cancer Can Achieve Substantial Complete Response Rates With Addition of Nivolumab - about 1 year ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Treatments - about 1 year ago
10	Wayne Kuznar MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors - about 1 year ago Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer - about 1 year ago Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer - about 1 year ago

Journalists covering Metastatic Breast Cancer